Investor mix
4 investors on record; lead investors include CHL Medical Partners, Healthcare Ventures; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 100% |
Small molecule therapeutics for degenerative eye diseases
4 investors on record; lead investors include CHL Medical Partners, Healthcare Ventures; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 100% |